PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infectious Diseases, Mayo Clinic, Rochester, MN; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN.\', \'Division of Infectious Diseases, Mayo Clinic, Rochester, MN.\', \'Division of General Internal Medicine, Mayo Clinic, Jacksonville, FL.\', \'Division of Infectious Diseases, Mayo Clinic, Jacksonville, FL.\', \'Division of Infectious Diseases, Mayo Clinic, Scottsdale, AZ.\', \'Division of General Internal Medicine, Mayo Clinic, Rochester, MN.\', \'Division of Primary Care Internal Medicine, Mayo Clinic Health System, La Crosse, WI.\', \'Department of Pharmacy, Mayo Clinic Health System, Eau Claire, WI.\', \'Division of Infectious Diseases, Mayo Clinic Health System, Eau Claire, WI.\', \'Division of Community Internal Medicine, Mayo Clinic, Rochester, MN.\', \'Division of Family Medicine, Mayo Clinic Health System, Mankato, MN.\', \'Division of Infectious Diseases, Mayo Clinic, Rochester, MN. Electronic address: Razonable.raymund@mayo.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0025-6196(21)00924-110.1016/j.mayocp.2021.12.002
?:hasPublicationType
?:journal
  • Mayo Clinic proceedings
is ?:pmid of
?:pmid
?:pmid
  • 35120695
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.551
?:rankingScore_hIndex
  • 153
?:title
  • Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35120695>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35120695>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all